Skip to main content

Table 5 Results of scintigraphic parameters in patients who had bile duct complications

From: Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients

Case and immunosuppression Case 1 CSA Case 2 TAC Case 3 CSA to TAC Case 4 CSA
Complications, time of the onset of treatment after LTx Bile duct stricture, 4 months Bile duct stricture, 1.5 months Bile duct stricture, 5 months Bile leakage after the removal of T-tube, 1 month
Treatment Dilatation and bile duct stent placement by ERCP, PTCD Dilatation and bile duct stent placement by ERCP, PTCD Dilatation and bile duct stent placement by ERCP Bile duct stent placement by ERCP, PTCD
3-month HEF (%) 46 14 13 29
Bilirubin, 3-month follow-up (μmol/l) 38 59 41 16
1-year HEF (%) 37 17 26 41
Bilirubin, 1-year follow-up (μmol/l) 8 146 142 18
  1. LTx, liver transplantation; ERCP, endoscopic retrograde cholangiopancreatography; PTCD, percutaneous transhepatic cholangio drainage.